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Abstract
Objective: To evaluate the costs and health outcomes associated with primary 
care use by Indigenous people with diabetes in remote communities in the 
Northern Territory.
Design, setting and participants: A population-based retrospective cohort 
study from 1 January 2002 to 31 December 2011 among Indigenous NT residents 
 15 years of age with diabetes who attended one of ﬁ ve hospitals or 54 remote 
clinics in the NT.
Main outcome measures: Hospitalisations, potentially avoidable 
hospitalisations (PAH), mortality and years of life lost (YLL). Variables included 
disease stage (new, established or complicated cases) and primary care use 
(low, medium or high).
Results: 14 184 patients were eligible for inclusion in the study. Compared with 
the low primary care use group, the medium-use group (patients who used 
primary care 2–11 times annually) had lower rates of hospitalisation, lower PAH, 
lower death rates and fewer YLL. Among complicated cases, this group showed 
a signiﬁ cantly lower mean annual hospitalisation rate (1.2 v 6.7 per person 
[P < 0.001]) and PAH rate (0.72 v 3.64 per person [P < 0.001]). Death rate and 
YLL were also signiﬁ cantly lower (1.25 v 3.77 per 100 population [P < 0.001] and 
0.29 v 1.14 per person-year [P < 0.001], respectively). The cost of preventing one 
hospitalisation for diabetes was $248 for those in the medium-use group and 
$739 for those in the high-use group. This compares to $2915, the average cost 
of one hospitalisation.
Conclusion: Improving access to primary care in remote communities for the 
management of diabetes results in net health beneﬁ ts to patients and cost 
savings to government .
 Australia’s Northern Territory has an estimated population of 234 800 people — just 1% of the 
national total. More than half the pop-
ulation lives in the greater Darwin area 
or in Alice Springs.1 Of all states and 
territories, the NT has the highest pro-
portion (30%) of Aboriginal and Torres 
Strait Islander peoples (Indigenous 
Australians), many of whom live in 
small communities in remote and very 
remote areas (remoteness area cate-
gories 3 and 4).2 Indigenous people 
continue to experience higher rates of 
unemployment, lower levels of educa-
tion and more crowded living condi-
tions compared with other Australians. 
These social determinants contribute 
to poor health, including higher rates 
of chronic diseases and hospitalisa-
tion, higher mortality and lower life 
expectancy.3
Primary care is an effective and 
effi cient means of providing a range 
of basic health services that improve 
health outcomes.4,5 However, pro-
viding high-quality, cost-effective 
primary care for a small population 
dispersed over a large remote area 
poses challenges. Cost-effectiveness 
refers to value for money, with better 
health outcomes achieved at less cost 
for patients as well as the health sys-
tem.6 Indigenous people in remote set-
tings experience barriers to accessing 
health services, including poor avail-
ability of general practitioners, geo-
graphical isolation, costs associated 
with travel and variable levels of cul-
tural safety.7,8 Rates of potentially 
 avoidable hospitalisations (PAHs) are 
indicators of access to primary care and 
include hospitalisations that may have 
been avoided by preventing illness or 
managing chronic disease.8
Undiagnosed or poorly controlled 
diabetes often results in serious 
complications leading to PAH, dis-
ability and premature death. In the 
NT between 1998–99 and 2005–06, 
Indigenous people were hospitalised 
for potentially avoidable causes at four 
times the rate of non-Indigenous peo-
ple. This was largely attributable to 
diabetes complications, and highlights 
barriers to accessing effective primary 
care.9 Together with other chronic dis-
eases, diabetes accounts for a large 
proportion of hospital resources, indi-
rect costs through loss of productivity 
and impacts on social and family life.10
 The NT is disadvantaged with 
regard to funding, as with fewer GPs 
in remote areas there is less Medicare 
and Pharmaceutical Benefi ts Scheme 
(PBS) subsidisation of consultations 
and prescribed medicines. Many 
health services in remote Indigenous 
communities are provided by nurses 
and Aboriginal health workers, whose 
services are largely not covered by 
Medicare or the PBS.11 This disadvan-
tage is compounded by the high cost 
of providing primary care in remote 
locations compared with equiva-
lent services in metropolitan areas.12 
Additional funds are provided by the 
federal government, but between 2003 
and 2012, there was a persistent gap 
of about $37 million annually between 
actual Medicare payments for NT res-
idents and expected payments based 
on the national average. The 2012 rate 
of use of the PBS was only one-quarter 
of the national average.13 These com-
parisons are based on a per capita 
share and do not take into account the 
greater health needs of the Indigenous 
population or the cost of delivering 
services.14
There appears to be a signifi cant 
need to improve availability of primary 
care services in remote communities 
in the NT. While the costs of provid-
ing these services are relatively high 
because of remoteness and a lack of 
economies of scale, there is a short-
age of cost-effectiveness data show-
ing whether there is a net benefi t in 
terms of health outcomes and costs of 
investing in primary care. We under-
took a population-based retrospective 
cohort study, from a health service per-
spective, to evaluate the costs and the 
health outcomes associated with pri-
mary care use by Indigenous people 
with diabetes in remote communities 
in the NT, using the incremental costs 
and benefi ts among a population of 
patients with different levels of pri-
mary care use.
The cost-eff ectiveness of primary care for 
Indigenous Australians with diabetes living 
in remote Northern Territory communities
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Methods
We linked two databases at the indi-
vidual level using patients’ unique hos-
pital registration numbers. Individuals 
were categorised to one of three groups 
based on their level of use of primary 
care services. Data were stratifi ed by 
disease stage. We compared marginal 
costs and marginal effects on health 
outcomes using hospitalisations, PAHs, 
deaths and years of life lost (YLL). We 
calculated cost-effectiveness ratios with 
95% confi dence intervals.15 All costs 
and monetary benefi ts are reported in 
2006–07 Australian dollars.
Inclusion criteria
Inclusion was restricted to residents of 
remote and very remote areas of the 
NT2 who had been diagnosed with 
diabetes; were aged 15 years and over 
as of 1 January 2002; identifi ed as 
Indigenous; and visited a public hospi-
tal in the NT or one of the remote clin-
ics managed by the NT Department of 
Health at least once during the study 
period. The quality of Indigenous sta-
tus reporting in NT hospital admission 
data is estimated to be 98% accurate.16
All primary care visits and hospi-
talisations of NT Indigenous patients 
in the catchment localities of the clin-
ics between 1 January 2002 and 31 
December 2011 were included for anal-
ysis. In the case of multiple residential 
localities, the locality with the highest 
frequency of recorded visits or hos-
pitalisations was used. Direct trans-
fers from clinics to hospital were not 
included in measures of use.
Classiﬁ cations
Diabetes was defined using the 
International Classifi cation of Primary 
Care, 2nd edition (ICPC-2)17 and 
the Australian Refi ned Diagnosis 
Related Groups, Version 4 (AR-DRG)18 
(Box 1). PAHs were identifi ed using the 
International Statistical Classifi cation 
of Diseases and Related Health 
Problems, Tenth Revision, Australian 
Modification (ICD-10-AM).19 The 
principal diagnosis and procedure 
codes and up to nine secondary codes 
were used to identify complications of 
diabetes and PAHs.20
Data sources
We used two administrative data-
bases: the primary care informa-
tion system (PCIS) and the Caresys 
hospital admission data system. Data 
from 54 remote clinics and all fi ve pub-
lic hospitals in the NT for the 10 years 
2002–2011 were extracted for statisti-
cal analysis.
We used the government account-
ing system to extract fi nancial data for 
primary care costs. Operational and 
personnel expenditures were allo-
cated based on activity. These expen-
ditures covered patient travel, property 
maintenance and cleaning, and sala-
ries for doctors, nurses and Aboriginal 
health workers. Costing informa-
tion was derived using a “top-down” 
approach based on the total remote 
health expenditure and total clinic 
visits. The mean cost per visit was 
derived by dividing the total recur-
rent expenditure by the total number 
of clinic visits. Hospitalisation costs 
were taken from the national hospital 
costing data collection which excluded 
capital expenditure and patient travel. 
Indigenous patients in remote com-
munities are not required to contrib-
ute a copayment for their care. We did 
not include any incidental costs borne 
by patients.
Statistical analysis
The two variables of interest were dis-
ease stage and primary care use. To 
defi ne disease stage, patients were allo-
cated to one of three groups depending 
on disease severity. ICD-10-AM and 
ICPC-2 were used to identify new cases 
and complicated cases. A new case was 
identifi ed by checking previous health 
records. A new dia gnosis was assumed 
if the patient did not have a previous 
diabetes-related hospital admission 
or clinic visit. The three groups were:
• New cases: patients with a new 
diagnosis and without complica-
tions, as identifi ed by applying the 
formula in Box 2;
• Established cases: patients who 
were neither a new nor a compli-
cated case;
• Complicated cases: patients with 
one or more disease complications 
in any fi eld of diagnosis, as defi ned 
in Box 1.
Patients were also allocated to one 
of three groups according to annual 
number of primary care visits:
• Low-use group: 0–1
• Medium-use group: 2–11
• High-use group:  12.
Recommended best practice in the 
CARPA (Central Australian Rural 
Practitioners Association) Standard 
Treatment Manual 5th edition was 
used to develop the range of annual 
visits for each group.21
Propensity score matching and 
weighting were used to improve the 
comparability of the three groups.22 
The propensity score was computed 
2  Criteria used for deciding a new case of diabetes
Data source Criteria*
Hospital data (last admission > 3 years AND no diabetes) OR
(last admission > 2 years AND no diabetes in the last two admissions) OR
(last admission > 1 month AND no diabetes in the last three admissions)
Primary care data (last visit > 1.5 years AND no diabetes) OR
(last visit > 1 year AND no diabetes in the last two visits) OR
(last visit > 1 month AND no diabetes in the last three visits) OR
(last visit  1 month AND no diabetes in the last four visits)
* A new case must satisfy one of the criteria in both hospital and primary care data. 
1  Disease groups, deﬁ nitions of diabetes and complications of diabetes
Coding Diabetes
Primary care ICPC-2 codes T87, T89, T90
Hospital AR-DRG codes F11A, F11B, F13Z, K01Z, K60A, K60B
Hospital ICD-10-AM codes E10-E14
ICPC-2 complication codes A07, F83, K01, K02, K74-K76, K86, K89, K90, K91, N94, U88
ICD-10-AM complication codes R40, R07, I20-I25, I10, G45, G46, I60-I69, H35, H36, G54-G64, N00-N19
ICPC-2 = International Classiﬁ cation of Primary Care, 2nd edition. AR-DRG = Australian Reﬁ ned Diagnosis Related Groups, version 
4. ICD-10-AM = International Classiﬁ cation of Diseases. 
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using key demographics and num-
bers of chronic diseases. A χ2 test was 
used to check comparability of the 
three groups.
Outcomes were measured in terms 
of annual hospitalisation rates (mean 
number of hospitalisations per per-
son); annual PAH rates; deaths per 
100 population; and YLL per per-
son for between-group comparison. 
Deaths were identifi ed using both 
PCIS and Caresys data. Age at death 
and Australian age-specifi c life expec-
tancy were used to estimate YLL. 
The level of signifi cance was set at 
P < 0.05. The cost-effectiveness ratio 
(CER) was calculated as the incremen-
tal cost per hospitalisation averted for 
both medium- and high-use groups, 
compared with the low-use alterna-
tive. If the CER is less than the “will-
ingness-to-pay” threshold (a criterion 
for determining cost-effectiveness), 
that level of use is deemed cost-effec-
tive.15 The mean hospitalisation cost 
in the NT in the 2006–07 fi nancial 
year was used as the threshold for 
hospitalisation assessment. The net 
benefi t, expressed in monetary terms, 
was evaluated on the basis of primary 
care costing, hospitalisations saved 
or YLLs averted and the willing-
ness-to-pay threshold. To assess the 
uncertainty relating to the cost-effec-
tiveness of primary care, we calcu-
lated a cost-effectiveness acceptability 
curve,15 which allows estimation of 
the probability that primary care is 
cost-effective in reducing hospital 
admissions or YLLs, against differ-
ent values placed on a hospital admis-
sion or a year of life. The statistical 
value of a life-year was $120 000 for 
the YLL assessment threshold.23 SAS 
9.3 (SAS Institute Inc) was used for 
statistical analysis.
Ethics approval for this project was 
obtained from the Northern Territory 
Department of Health and Menzies 
School of Health Research Ethics 
Committee (Approval Number: 2012-
184) and from the Central Australian 
Human Research Ethics Committee 
(HREC 12-57).
Results
A total of 14 184 patients were eligi-
ble to be included in the study. After 
propensity score matching, there 
were no signifi cant differences in age 
(P = 0.980), sex (P = 0.354) or number 
of comorbidities (P = 0.348) between 
the low-, medium- and high-use 
groups. The mean cost per primary 
care visit in 2007–08 was estimated 
at $175. The mean cost per hospital-
isation was $2915 (AR-DRG hospital 
inpatient costing is based on 2007–08 
and 2008–09 fi nancial year fi gures).
Overall, compared with the low-
use group, the medium- and high-
use groups (patients who used primary 
care two or more times annually) expe-
rienced lower rates of annual hospital-
isation, PAH and death and fewer YLL 
(Box 3). Among complicated cases, the 
medium-use group had a lower mean 
annual hospitalisation rate than the 
low-use group (1.2 v 6.7 hospitalisa-
tions per person [P < 0.001]); the mean 
annual PAH rate was lower (0.72 v 3.64 
3  Mean annual hospitalisation, potentially avoidable hospitalisation, death rate and years of life lost for Indigenous people 
with diabetes in remote communities in the Northern Territory, by primary care use group, 2002–2011
Mean annual rate (95% CI)
No. of patients, and 
outcomes, by disease stage
Low-use group (0–1 primary care 
annual visits; n = 1421)
Medium-use group (2–11 primary 
care annual visits; n = 1892)
High-use group ( 12 primary 
care annual visits; n = 772)
New cases n = 119 n = 63 n = 18
Established cases n = 278 n = 393 n = 50
Complicated cases n = 1024 n = 1436 n = 704
Hospitalisations per person
New cases 0.7 (0.58–0.89) 0.8 (0.59–1.04) 0.9 (0.46–1.36)
Established cases 0.4 (0.36–0.52) 0.7 (0.60–0.77) 0.3 (0.16–0.48)
Complicated cases 6.7 (6.56–6.88) 1.2 (1.18–1.30) 1.0 (0.94–1.09)
Total 5.0 (4.87–5.11) 1.1 (1.06–1.16) 1.0 (0.89–1.04)
Avoidable hospitalisations per person
New cases 0.31 (0.21–0.42) 0.35 (0.20–0.50) 0.38 (0.09–0.67)
Established cases 0.20 (0.14–0.25) 0.38 (0.32–0.44) 0.11 (0.02–0.21)
Complicated cases 3.64 (3.52–3.76) 0.72 (0.68–0.77) 0.57 (0.51–0.63)
Total 2.69 (2.60–2.78) 0.64 (0.60–0.67) 0.54 (0.48–0.59)
Deaths per 100 population
New cases 2.17 (1.32–3.02) 0.48 (0.00–1.03) 0.00 (–)
Established cases 1.65 (1.17–2.14) 0.15 (0.03–0.28) 0.46 (0.00–1.06)
Complicated cases 3.77 (3.39–4.16) 1.25 (1.06–1.43) 0.84 (0.62–1.06)
Total 3.23 (2.92–3.53) 0.99 (0.85–1.14) 0.80 (0.59–1.00)
Years of life lost per person
New cases 0.81 (0.76–0.86) 0.13 (0.10–0.16) 0.00 (–)
Established cases 0.57 (0.54–0.60) 0.05 (0.04–0.06) 0.21 (0.17–0.25)
Complicated cases 1.14 (1.12–1.16) 0.29 (0.28–0.30) 0.20 (0.19–0.21)
Total 1.00 (0.99–1.02) 0.24 (0.23–0.24) 0.20 (0.19–0.21)
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per person [P < 0.001]); and the death 
rate and YLL were also lower (1.25 v 
3.77 per 100 population [P < 0.001] and 
0.29 v 1.14 per person-year [P < 0.001], 
respectively). Only marginal differ-
ences were observed for patients 
using primary care  12 times annu-
ally. For new cases in the medium-
use group compared with the low-use 
group, the death rate was lower (0.48 
v 2.17 per 100 population [P = 0.001]), 
as were YLL (0.13 v 0.81 per person-
year [P < 0.001]). Lower rates were also 
shown for established cases in the 
medium-use group compared with 
the low-use group (deaths, 0.15 v 1.65 
per 100 population [P < 0.001]; YLL, 
0.05 v 0.57 per person-year [P < 0.001]).
The net health benefi ts in saved hos-
pitalisations provide a summary meas-
ure for the value-for-money of primary 
care. The net health benefi t, as meas-
ured by hospitalisations saved per per-
son per year, is achieved at a lower cost 
when primary care is used between 
two and 11 times per year. While 
higher use of primary care achieves 
slightly greater net benefi ts, it does so 
at a greater cost as measured by will-
ingness to pay (Box 4).
Using 2007–08 and 2008–09 fi nan-
cial year fi gures, there is an almost 
100% probability that both medium 
and high primary care use are cost-
effective in terms of hospitalisations 
avoided (Box 5).
Investing $1 in medium-level pri-
mary care for people with diabetes in 
remote Indigenous communities could 
save $12.90 in hospitalisation costs. 
Investing $1 in high-level primary care 
use could save $4.20.
The cost of preventing one hospi-
talisation for diabetes was $248 for 
those in the medium-use group and 
$739 for those in the high-use group. 
In both cases the cost was much less 
than the mean cost of one hospitali-
sation, $2915.
Uncertainty in the cost and effect 
estimates was assessed by 2000 boot-
strapped simulations (Box 6).
Discussion
In the NT, improving the availability 
of primary care services is the key to 
improving access.7 The current model 
of service delivery in the NT results in 
low rates of primary care use and high 
rates of hospitalisation, suggesting 
patients with diabetes are not receiving 
4  Net beneﬁ ts in hospitalisations avoided with 95% conﬁ dence intervals, by 
willingness-to-pay per hospitalisation
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optimal care aimed at monitoring and 
preventing complications. Investment 
in primary care in remote areas in the 
NT is costly compared with metropol-
itan settings.12 However, the alterna-
tive, hospital-based care, is even more 
expensive and results in poorer health 
outcomes. Our study has shown that 
improving use of primary care would 
not only yield better health outcomes 
for patients with diabetes, but would 
be cost-effective. The savings calcu-
lated in this study could be increased 
by improving the social determinants 
of health, in which process primary 
care has an important role through 
intersectoral action.4
These results are valuable to policy-
makers and health service planners 
charged with resource allocation. 
While there is general agreement 
in the international literature that 
improved access to primary health 
care results in fewer PAHs,24 evidence 
that this is true for remote communi-
ties in Australia and that this is cost-
effective is scarce.25 Our study shows 
that improved access to primary care is 
both cost-effective and associated with 
better health outcomes for residents 
of remote communities. The results 
may be generalisable for other chronic 
diseases and to other jurisdictions in 
Australia. They may also be relevant 
to other countries where remoteness 
poses similar challenges.
The results are also of value to pri-
mary care managers and service pro-
viders who can aim to ensure their 
patients with diabetes are using ser-
vices adequately (2–11 times per year). 
In Indigenous communities, it is par-
ticularly important that primary care 
services are culturally appropriate 
and refl ect community preferences, 
including connection to culture, fam-
ily and land, and opportunity for 
self-determination.26
Our study has l imitations. 
Researchers did not have access to 
mortality data beyond 2007 and used 
hospital and PCIS mortality data only, 
so some deaths may have been missed. 
We did not have access to data from 
Aboriginal Community Controlled 
Health Services, and acknowledge that 
some patients may have been using 
primary care elsewhere. Some patients 
undergoing renal dialysis in hospi-
tal may have obtained primary care 
there rather than in their home com-
munity. A sensitivity analysis revealed 
that eliminating renal dialysis hospi-
talisations made little difference to the 
outcome (results are not reported). We 
did not include costs incurred in trans-
porting patients from remote locations 
to hospital, so the total costs of hospi-
talisation are an underestimation. We 
were not able to eliminate any poten-
tial confounding effects of distances 
from patient’s residence to clinics or 
to hospital due to lack of data on geo-
coded localities.
Indigenous people in remote com-
munities in the NT experience high 
rates of diabetes and poor access to 
primary care with resultant high mor-
tality, morbidity and hospitalisation 
rates. This study used reliable, linked 
data to provide new evidence that there 
are signifi cant cost savings and bet-
ter health outcomes for patients with 
diabetes when access to primary care 
is improved.
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